Integrated Diagnostics Holdings Plc

Integrated Diagnostics (IDHC)

Buy
Sell
Company name:Integrated Diagnostics Holdings Plc
EPIC:IDHCTrading Currency:USD
Market Sector:SMEVISIN:JE00BLKGSR75
Market Segment:SSMUShare Type:DE
WWW Address:http://www.idhcorp.com/Description:ORD USD0.25
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 0.76 images.advfn.com/imagesnew/2/gb/up 0.005 [0.66] 0.75 0.77 0.77 0.77 0.75 115,417
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 114.09 150.11 -0.00 7.93 - 9.58 - 1.45 - 0.66

Integrated Diagnostics Key Figures

(at previous day's close)
Market Cap.114.09m
Shares In Issue150.11m
Prev. Close0.76
PE Ratio9.58 
Dividend Yield-%
EPS - basic7.93¢($)
Dividend PS-¢($)
Dividend Cover- 
Cash Flow PS71.21¢($)
Return On Equity (ROE)54.69%
Operating Margin42.73%
PEG Factor0.07 
EPS Growth Rate137.37%
Dividends PS Growth Rate-%
Net Debt120.10m
Gross Gearing55.19%
Quick Assets64.10m
Net Working Capital-36.03m
Intangibles / Fixed Assets35.66%
Turnover PS163.91¢($)
Pre-Tax Profit PS70.03¢($)
Retained Profit PS29.30¢($)
Cash PS27.97¢($)
Net Cash PS-45.72¢($)
Net Tangible Asset Value PS *28.99¢($)
Net Asset Value PS87.66¢($)
Spread0.02 (2.60%) 

Integrated Diagnostics Balance Sheet

L^IDHC:Liabilities+EQL^IDHC:Assets

Share Price Performance

Sample Period HighLow
1 week0.790.73
4 weeks0.820.73
12 weeks0.920.73
1 year1.450.66

Share Price Chart (5 years)

Integrated Diagnostics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week0.78-0.02-2.560.730.330.75
4 weeks0.77-0.01-1.300.730.280.76
12 weeks0.89-0.13-14.410.730.500.79
26 weeks0.94-0.18-19.150.660.450.83
1 year1.29-0.53-40.860.660.350.94
3 years4.82-4.06-84.230.660.201.32
5 years4.40-3.64-82.730.660.161.92

Integrated Diagnostics Key Management Ratios

Integrated Diagnostics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio1.15 
PE Ratio9.58 
Tobin's Q Ratio 0.02 
Tobin's Q Ratio (excl. intangibles)0.03 
Dividend Yield-%
Market-to-Book Ratio0.94 
Price-to-Pre-Tax Profit PS1.09 
Price-to-Retained Profit PS2.59 
Price-to-Cash Flow PS1.07 
Price-to-Sales PS0.46 
Price-to-Net Tangible Asset Value PS2.13 
Price-to-Cash PS2.72 
Net Working Capital PS-24.00 
Price Pct to Working Capital PS-3.17%
Earnings Yield10.44%
Average PE0.01 
Years in average5 
PE to PE average80,872.20%

Integrated Diagnostics Financial Ratios

(Leverage Ratios)
Debt Ratio28.11%
Debt-to-Equity Ratio0.39 
Debt-to-Equity Ratio (excl. Intgbl)0.96 
Debt-to-Equity Market Value0.45 
Net Gearing40.90%
Net Gearing (excl. Intangibles)55.72%
Gross Gearing55.19%
Gross Gearing (excl. Intangibles)75.19%
Gearing Under 1 Year37.67%
Gearing Under 1 Year (excl. Intgbl)51.32%
Assets/Equity2.23 
Cash/Equity31.90 
(Liquidity Ratios)
Net Working Capital to Total Assets-12.27%
Current Ratio0.67 
Quick Ratio (Acid Test)0.58 
Liquidity Ratio0.38 
Cash & Equiv/Current Assets56.29%
(Solvency Ratios)
Enterprise Value133.53m
CFO/Sales0.43 
CFO/Attributable Profit1.61 
CFO/Assets0.36 
CFO/Debt0.66 
Total Debt/Equity Market Value1.42 
Total Debt/Sales0.66 
Total Debt/Pre-Tax Profit1.54 
Total Debt162.08m
Total Debt/Net Current Assets-4.50%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
-0.0005-0.0021

Integrated Diagnostics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)57.43%
Return On Assets (ROA)1.28%
Net Profit Margin27.04%
Assets Turnover0.05 
Return On Equity (ROE)54.69%
Return On Investment (ROI)1.89%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio2.74%
Net Income Of Revenues17.87%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.10 
Fixed Assets Turnover0.06 
Current Assets Turnover0.18 
Net Working Capital Turnover 
Inventory Turnover1.52 
(Other Operating Ratios)
Total Assets-to-Sales21.16 
Debtors-to-Sales173.38%
Debt Collection Period632.84Days

Integrated Diagnostics Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
17 Jun 2020FinalUSX4.9031/12/201931/12/202008/07/202109/07/202129/07/202123.60
02 Sep 2020InterimUSX18.7030/12/201930/06/202010/09/202011/09/202002/10/2020-

Integrated Diagnostics Fundamentals

 31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)31 Dec 2021 (EGP)
turnover1,921.45100.00%2,226.49100.00%2,656.26100.00%5,224.71100.00%m
pre tax profit717.3637.33%758.1434.05%969.0836.48%2,232.3242.73%m
attributable profit502.0926.13%510.9322.95%594.0122.36%1,412.6127.04%m
retained profit67.143.49%60.432.71%143.285.39%933.8617.87%m
eps - basic335.00 341.00 99.00 235.00 
eps - diluted335.00 341.00 99.00 235.00 
dividends per share- - 23.60 - 

Integrated Diagnostics Balance Sheet

 31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)31 Dec 2021 (EGP)
L^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:AssetsL^IDHC:Liabilities+EQL^IDHC:Assets
 31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)31 Dec 2021 (EGP)
ASSETS
fixed assets fixed assets705.7820.55%785.5520.92%793.0118.98%1,524.2424.44%m
intangibles intangibles1,672.4648.71%1,925.6051.27%2,014.4448.22%1,658.8726.60%m
fixed investments fixed investments239.906.99%228.016.07%286.236.85%1,469.1923.56%m
current assets - other current assets - other--%--%--%--%m
stocks stocks91.082.65%84.342.25%100.122.40%222.613.57%m
debtors debtors299.998.74%322.808.60%383.489.18%469.737.53%m
cash & securities cash & securities424.5712.36%409.1410.89%600.1314.37%891.4514.30%m
TOTAL3,433.79100%3,755.44100%4,177.41100%6,236.09100%m
LIABILITIES
creditors - short creditors - short669.3219.49%828.2222.05%1,009.3624.16%2,348.9237.67%m
creditors - long creditors - long363.8310.60%566.9615.10%741.6717.75%1,092.8117.52%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL1,033.1530.09%1,395.1837.15%1,751.0441.92%3,441.7355.19%m
EQUITY
ord cap, reserves ord cap, reserves2,270.0566.11%2,215.5559.00%2,269.9954.34%2,582.8541.42%m
prefs, minorities prefs, minorities130.593.80%144.713.85%156.383.74%211.513.39%m
TOTAL2,400.6469.91%2,360.2662.85%2,426.3758.08%2,794.3644.81%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Integrated Diagnostics Cash Flow Statement

31 Dec 2018 (EGP)31 Dec 2019 (EGP)31 Dec 2020 (EGP)31 Dec 2021 (EGP)
Operating CF556.31697.41882.522,269.84m
Pre-Financing CF90.69561.06758.25942.00m
Retained CF-268.0412.33194.71294.85m

Integrated Diagnostics Brokers

Broker infomation is not available for this class of stock.
Your Recent History
LSE
IDHC
Integrated..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221128 02:27:59